Trials / Completed
CompletedNCT00091481
Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis
A Randomized, Active-Controlled, Double-Blind Multi-Center Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 201 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To show non-inferiority in the incidence rates of elevated calcium-phosphorus product between two treatment groups: 1) a group having an initial dose based on baseline PTH (baseline iPTH/80) and 2) a group having a starting dose based on body weight (0.04 mcg/kg).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zemplar |
Timeline
- Start date
- 2003-06-01
- First posted
- 2004-09-13
- Last updated
- 2007-09-26
Locations
19 sites across 1 country: Greece
Source: ClinicalTrials.gov record NCT00091481. Inclusion in this directory is not an endorsement.